Main > A1. CORP. INDEX. A-Am No. 2 > Acer Therapeutics Inc./P C2



Acer Therapeutics Inc./P C2's subsections
2017. 09.20. Merger Opexa ..
2019. 01.02. Sanofi In-License
2021. 10.26. USA Patent
2022. 02.01. USA Patent
2023. 05.01. USA Comm. Launch>
2023. 08.31. Acq. By Zevra Therap
2023. 11.20. Acq. By Zevra Therap
web-site

Acer Therapeutics Inc./P C2's products
This section has no products